|
1. Biologie
|
|
|
|
3.3 Prévention - Vaccins
|
|
|
Fears for women’s health as parents reject HPV vaccine [The Guardian]
|
|
|
|
|
|
Last
week, doctors and health officials gathered in Dublin – centre of one
of the most vociferous anti-vaccine campaigns – to discuss future
tactics. Many believe the use of social media has added new impetus to
anti-vaccine campaigners’ protests, and that this factor has been
closely involved in the success of the attacks that have been made on
immunisation programmes.
|
|
|
|
|
|
|
3.6 Prévention - Activité physique
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
5.12 Immunothérapies
|
|
|
|
|
5.12.4 Immunothérapies - Essais
|
|
|
Expanding Cancer Clinical Trial Access for Patients with HIV [NCI]
|
|
|
|
|
|
For
many years, NCI has recommended that people with HIV should not be
arbitrarily excluded from cancer clinical trials and has enrolled people
with HIV in immunotherapy trials. Early results from one such
NCI-sponsored trial appear to validate the inclusion of appropriately
selected HIV-positive people in immunotherapy clinical trials.
|
|
|
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
March 2019: EMA Updates Guidance on Brexit [RAPS]
|
|
|
|
|
|
The
European Medicines Agency (EMA) and the European Commission on Friday
updated guidance for pharmaceutical companies on the UK’s departure from
the EU, much of which hinges on March 2019 deadlines.
|
|
|
|
|
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA)
|
|
|
|
FDA approves first biosimilar for the treatment of certain breast and stomach cancers [FDA]
|
|
|
|
|
|
The
FDA’s approval of Ogivri is based on review of evidence that included
extensive structural and functional characterization, animal study data,
human pharmacokinetic and pharmacodynamic data, clinical immunogenicity
data and other clinical safety and effectiveness data that demonstrates
Ogivri is biosimilar to Herceptin. Ogivri has been approved as a
biosimilar, not as an interchangeable product.
|
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
6.6 Publications
|
|
|